BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.170
+0.050 (1.60%)
At close: May 13, 2025, 4:00 PM
3.190
+0.020 (0.63%)
Pre-market: May 14, 2025, 7:13 AM EDT
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$724,500
Market Cap
18.20M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% |
| Jul 31, 2021 | 6 | 0 | - |
| Aug 1, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BCTX News
- 14 days ago - BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified - GlobeNewsWire
- 15 days ago - BriaCell Therapeutics Announces Closing of $13.8 million Public Offering - GlobeNewsWire
- 16 days ago - BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development - GlobeNewsWire
- 19 days ago - BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering - GlobeNewsWire
- 19 days ago - Nano-Cap BriaCell Confirms Full Resolution Of Lung Metastasis In Breast Cancer Trial, Stock Shoots Higher - Benzinga
- 20 days ago - BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™ - GlobeNewsWire
- 21 days ago - BriaCell Announces Four Clinical Data Presentations at ASCO 2025 - GlobeNewsWire
- 22 days ago - BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC) - GlobeNewsWire